Search research articles
Contact Us
Filters
Showing results (181-190 of 255) with videos related to
Page
of 26
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
October 5, 2025
Changes in Frailty Categorization Over One Year among Real-World Patients With Multiple Myeloma: A Prospective Cohort Study (MFRAIL)
Imran Haider, Darryl P Leong, Omar Shahid, et al.
Journal of Medical Internet Research
|
January 18, 2023
Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial
Bojana Petrovic, Jim A Julian, Clare Liddy, et al.
NEJM Evidence
|
May 26, 2026
Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer
Mark Clemons, Carol Stober, Gregory R Pond, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 19, 2017
A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group
Scott A Laurie, Desiree Hao, Natasha B Leighl, et al.
Cancer
|
February 21, 2008
Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation
Arwa Abdelhameed, Gregory R Pond, Nicholas Mitsakakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors
Ignacio Duran, Sebastien J Hotté, Holger Hirte, et al.
Clinical Genitourinary Cancer
|
June 27, 2013
Impact of response to prior chemotherapy in patients with advanced urothelial carcinoma receiving second-line therapy: implications for trial design
Gregory R Pond, Joaquim Bellmunt, Ronan Fougeray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2014
Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial
Pamela J Goodwin, Roanne J Segal, Michael Vallis, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2004
Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status
Mala Bahl, Lillian L Siu, Gregory R Pond, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 25, 2022
Using machine learning to predict individual patient toxicities from cancer treatments
Katherine Marie Cole, Mark Clemons, Sharon McGee, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 255) with videos related to
Sort By:
Page
of 26
Clinical Lymphoma, Myeloma & Leukemia
|
October 5, 2025
Changes in Frailty Categorization Over One Year among Real-World Patients With Multiple Myeloma: A Prospective Cohort Study (MFRAIL)
Imran Haider, Darryl P Leong, Omar Shahid, et al.
Journal of Medical Internet Research
|
January 18, 2023
Web-Based Asynchronous Tool to Facilitate Communication Between Primary Care Providers and Cancer Specialists: Pragmatic Randomized Controlled Trial
Bojana Petrovic, Jim A Julian, Clare Liddy, et al.
NEJM Evidence
|
May 26, 2026
Every Six-Month versus Single-Dose Adjuvant Zoledronate in Early Breast Cancer
Mark Clemons, Carol Stober, Gregory R Pond, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 19, 2017
A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group
Scott A Laurie, Desiree Hao, Natasha B Leighl, et al.
Cancer
|
February 21, 2008
Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation
Arwa Abdelhameed, Gregory R Pond, Nicholas Mitsakakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors
Ignacio Duran, Sebastien J Hotté, Holger Hirte, et al.
Clinical Genitourinary Cancer
|
June 27, 2013
Impact of response to prior chemotherapy in patients with advanced urothelial carcinoma receiving second-line therapy: implications for trial design
Gregory R Pond, Joaquim Bellmunt, Ronan Fougeray, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2014
Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial
Pamela J Goodwin, Roanne J Segal, Michael Vallis, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2004
Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status
Mala Bahl, Lillian L Siu, Gregory R Pond, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 25, 2022
Using machine learning to predict individual patient toxicities from cancer treatments
Katherine Marie Cole, Mark Clemons, Sharon McGee, et al.
Page
of 26